JCCC Seminar Featuring Dr. Matthew Rettig
NON-Mutated Kinases as Pharmacologic Targets for the Treatment of Cancer
12:00 PM - 1:00 PM
10833 Le Conte Ave.
Los Angeles, California 90095
Matthew Rettig, M.D.
Professor-in-Residence, Departments of Medicine and Urology
Medical Director, Prostate Cancer Program
Associate Director, Hematology-Oncology Fellowship Program
Chief, Division of Hematology-Oncology
Member of the JCCC Cancer and Stem Cell Biology Program Area
Dr. Matthew Rettig's research focuses on the molecular and cellular biology of multiple myeloma, the role of human herpesvirus-8 in pathogenesis of myeloma and latent human herpesvirus-8 proteins that upregulate the transcription of cellular interleukin-6.
Light lunch served
Sponsored by the JCCC Cancer and Stem Cell Biology Program Area\